VIA
ASPX

Vident Investment Advisory’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

Vident Investment Advisory’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-19,790
Closed -$1.98M – 1080
2015
Q1 		$1.98M Buy
+19,790
New +$1.32M 0.4% 26

Vident Investment Advisory's ASPX Position: Q2 2015 in Review

Vident Investment Advisory sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 19,790 shares — an estimated $1.98M sold.

Vident Investment Advisory first reported a position in ASPX in Q1 2015 and held it in 1 quarter. The position peaked at $1.98M in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • Vident Investment Advisory reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Vident Investment Advisory sold 19,790 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.98M.
  • Vident Investment Advisory first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Vident Investment Advisory's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $1.98M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Vident Investment Advisory's 13F filing for Q2 2015, filed 29 Jul 2015.